This observation is consistent with BRCA1 c.5407-25T>A, playing a role in OC risk, as has been shown with LOH analyses of OC tumor DNA from those harboring loss-of-function pathogenic variants in BRCA1 [45]. This evidence concerns the gene BRCA1 and neoplasm.